-
公开(公告)号:BRPI0501648A
公开(公告)日:2006-12-12
申请号:BRPI0501648
申请日:2005-04-06
Applicant: BAXTER INT
Inventor: WERLING JANE , KIPP JAMES E , SRIRAM RAJARAM , DOTY MARK J , REBBECK CHRISTINE L , WONG JOSEPH CHUNG TAK
IPC: A61K9/00 , A61K9/127 , A61K9/14 , A61K31/495
-
公开(公告)号:AU2006201943A1
公开(公告)日:2006-06-01
申请号:AU2006201943
申请日:2006-05-10
Applicant: BAXTER INT
Inventor: SRIRAM RAJARAM , KIPP JAMES E , BRYNJELSEN SEAN , DOTY MARK J , WERLING JANE , REBBECK CHRISTINE L , WONG JOSEPH CHUNG TAK
-
公开(公告)号:BRPI0409929A
公开(公告)日:2006-04-25
申请号:BRPI0409929
申请日:2004-04-29
Applicant: BAXTER INT
Inventor: RABINOW BARRETT E , WHITE RANDY , SUN CHONG-SON , WONG JOSEPH CHUNG TAK , KIPP JAMES E , DOTY MARK J , REBBECK CHRISTINE L , PAPADOPOULOS PAVLOS
IPC: A61K9/50 , A61K9/51 , A61K31/496 , A61K9/14
Abstract: The present invention relates to compositions of submicron- to micron-size particles of antimicrobial agents. More particularly the invention relates to a composition of an antimicrobial agent that renders the agent potent against organisms normally considered to be resistant to the agent. The composition comprises an aqueous suspension of submicron-tomicron-size particles containing the agent coated with at least one surfactant selected from the group consisting of: ionic surfactants, non-ionic surfactants, biologically derived surfactants, and amino acids and their derivatives. The particles have a volume-weighted mean particle size of less than 5 µm as measured by laser diffractonetry.
-
公开(公告)号:NO20054908A
公开(公告)日:2005-12-21
申请号:NO20054908
申请日:2005-10-24
Applicant: BAXTER INT
Inventor: KIPP JAMES E , WONG JOSEPH CHUNG TAK , WISLER MONTE , GARCIA RHONDA
CPC classification number: A61K9/145 , A61K9/10 , Y10S516/924 , Y10S516/925 , Y10S977/84
-
公开(公告)号:BR0116377A
公开(公告)日:2005-12-13
申请号:BR0116377
申请日:2001-12-20
Applicant: BAXTER INT
Inventor: KIPP JAMES E , WONG JOSEPH CHUNG TAK , DOTY MARK J , REBBECK CHRISTINE L , BRYNJELSEN SEAN , WERLING JANE , SRIRAM AJARAM
-
公开(公告)号:BR0315215A
公开(公告)日:2005-08-16
申请号:BR0315215
申请日:2003-10-02
Applicant: BAXTER INT
Inventor: WONG JOSEPH CHUNG TAK , KIPP JAMES E , DOTY MARK J , REBBECK CHRISTINE L , PAPADOPOULOS PAVLOS
IPC: A61K9/10 , A61K9/14 , A61K9/16 , A61K9/50 , A61K31/495 , A61K31/496
Abstract: The present invention relates to compositions of submicron-to micron-size particles of antifungal agents. More particularly the invention relates to aqueous suspensions of antifungal agents for pharmaceutical use.
-
公开(公告)号:AU2005209243A1
公开(公告)日:2005-08-11
申请号:AU2005209243
申请日:2005-01-21
Applicant: BAXTER HEALTHCARE SA , BAXTER INT
Inventor: CHAUBAL MAHESH V , RABINOW BARRETT E , WERLING JANE , KIPP JAMES E
IPC: A61K9/10 , A61K9/14 , A61K9/51 , A61K31/00 , A61K31/551 , A61K31/7072 , A61K31/7076
Abstract: The present invention provides compositions comprising dispersions of anti-retroviral agents and methods of manufacture. The nanosuspensions are made by the process of microprecipitation and energy addition. Preferably, the nanosuspensions are made by the tandem process of microprecipitation-homogenization.
-
公开(公告)号:AU2001249766B2
公开(公告)日:2004-10-07
申请号:AU2001249766
申请日:2001-03-30
Applicant: BAXTER INT
Inventor: EILERT JAN Y , REBBECK CHRISTINE L , DOTY MARK J , KIPP JAMES E
IPC: A61K9/08 , A61K9/00 , A61K31/34 , A61K31/343 , A61K47/04 , A61K47/10 , A61K47/12 , A61K47/18 , A61K47/20 , A61K47/26 , A61P9/06 , A61K047/00 , A61K031/34 , A61K047/12 , A61K047/20
-
公开(公告)号:CA2517589A1
公开(公告)日:2004-09-30
申请号:CA2517589
申请日:2004-02-25
Applicant: BAXTER INT
Inventor: WONG JOSEPH CHUNG TAK , KIPP JAMES E , WERLING JANE , REBBECK CHRISTINE L , BRYNJELSEN SEAN , DOTY MARK J
IPC: A61K9/10 , A61K9/14 , A61K9/16 , A61K31/12 , A61K31/337 , A61K31/495 , A61K31/496 , A61K31/55 , A61K31/573
Abstract: The present invention is concerned with the formation of small particles or organic compounds by precipitating the organic compounds in an aqueous mediu m to form a pre-suspension followed by adding energy to stabilize a coating of the particle or to alter the lattice structure of the particle. The process includes the steps of: (i) dissolving the organic compound in the water- miscible first solvent to form a solution; (ii) mixing the solution with the second solvent to define a presuspension of particles; and (iii) adding ener gy to the presuspension to form a suspension of particles having an average effective particle size of less than about 100 .mu.m. The process is preferably used to prepare a suspension of small particles of a poorly water - soluble, pharmaceutically active compound suitable for in vivo delivery by a n administrate route such as parenteral, oral, pulmonary, nasal, buccal, topic al ophthalmic, rectal, vaginal, transdermal or the like.
-
公开(公告)号:AU2004222362A1
公开(公告)日:2004-09-30
申请号:AU2004222362
申请日:2004-02-25
Applicant: BAXTER INT
Inventor: KIPP JAMES E , WONG JOSEPH CHUNG TAK , WERLING JANE , REBBECK CHRISTINE L , BRYNJELSEN SEAN
IPC: A61K9/10 , A61K9/14 , A61K9/16 , A61K31/12 , A61K31/337 , A61K31/495 , A61K31/496 , A61K31/55 , A61K31/573
Abstract: The present invention is concerned with the formation of small particles of organic compounds by precipitating the organic compounds in an aqueous medium to form a pre-suspension followed by adding energy to stabilize a coating of the particle or to alter the lattice structure of the particle. The process includes the steps of: (i) dissolving the organic compound in the water-miscible first solvent to form a solution; (ii) mixing the solution with the second solvent to define a presuspension of particles; and (iii) adding energy to the presuspension to form a suspension of particles having an average effective particle size of less than about 100 mum. The process is preferably used to prepare a suspension of small particles of a poorly water-soluble, pharmaceutically active compound suitable for in vivo delivery by an administrate route such as parenteral, oral, pulmonary, nasal, buccal, topical ophthalmic, rectal, vaginal, transdermal or the like.
-
-
-
-
-
-
-
-
-